Population
Reovirus particles (ISVPs, ISVP*, core particles) and cells in culture / erythrocytes
Comparison
Antibody reagents and recoated particles with… vs Native ISVPs and recoated particles with…
Design
Preclinical
Authors
Loading...
Advances reovirus entry models in animals; leaves open human therapeutic implications for oncolytic virotherapy.
The study elucidates the structural changes and disassembly steps of reovirus particles during cell entry, identifying ISVP* as a key transient intermediate for membrane penetration.
Chandran et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: